Decibel Therapeutics, A Clinical-Stage Biotechnology Company, Announced That The European Medicines Agency (Ema) Committee On Orphan Medicinal Products (Comp) Has Issued A Positive Opinion On Orphan Drug Designation For Db-Oto, Decibel
Found this useful? Share it with your team.
